In vitro mutagenesis assays as predictors of chemical carcinogenesis in mammals
- PMID: 404113
- DOI: 10.3109/15563657708987961
In vitro mutagenesis assays as predictors of chemical carcinogenesis in mammals
Abstract
In vitro microbial mutagenesis assays coupled with mammalian activation systems offer promising technique to screen chemicals for their potential carcinogenic activity. The correlation between mutagenic and carcinogenic properties for a large array of chemicals is approximately 0.9. The best correlation exists for those carcinogens which are themselves highly electrophilic or produce electrophilic metabolites. Correlation between mutagenicity and carcinogenicity for hormonal, metallic, or physical carcinogens has been disappointing but not unexpected based on their proposed mechanisms of action. In addition to the application of in vitro mutagenesis techniques to screening chemicals for the identification of potential carcinogens, they are useful tools for investigating genetic, biochemical, and pharmacologic properties of different animal species. Studies with the chemical carcinogen dimethylnitrosamine have been conducted and show a functional relationship between mutagenesis and carcinogenesis. The assays can also be conducted using activation systems prepared from the tissues of any mammalian species. This permits a direct assessment of phylogenic extrapolation by comparing the metabolic activation capabilities of tissues from several mammalian species, including human samples. The advantages of mutagenicity testing are the short period of time required for results, the high sensitivity of the assay (microgram of nanogram quantities of chemicals can be used), and the fact that the ultimate agent can be detected biologically without first necessitating chemical identification and isolation. It appears from current studies that in vitro mutagenesis techniques may well open new avenues of investigation into some old toxicologic problems.
Similar articles
-
In vitro carcinogenesis with cells in early passage.Natl Cancer Inst Monogr. 1978 May;(48):245-57. Natl Cancer Inst Monogr. 1978. PMID: 372816 Review.
-
The results of assays in Drosophila as indicators of exposure to carcinogens.IARC Sci Publ. 1999;(146):427-70. IARC Sci Publ. 1999. PMID: 10353398 Review.
-
Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.Cancer Res. 1979 Mar;39(3):682-93. Cancer Res. 1979. PMID: 371791
-
In vitro assays for recombinogenic activity of chemical carcinogens and related compounds with Saccharomyces cerevisiae D3.J Natl Cancer Inst. 1979 Apr;62(4):901-9. J Natl Cancer Inst. 1979. PMID: 372658
-
Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.Cancer Res. 1987 Mar 1;47(5):1287-96. Cancer Res. 1987. PMID: 3815340
Cited by
-
Analyzing the dose-dependence of the Saccharomyces cerevisiae global transcriptional response to methyl methanesulfonate and ionizing radiation.BMC Genomics. 2006 Dec 1;7:305. doi: 10.1186/1471-2164-7-305. BMC Genomics. 2006. PMID: 17140446 Free PMC article.
-
Mutagenicity studies of 4-(2-carboxyethyl) phenyl trans-4-aminomethylcyclohexane carboxylate hydrochloride (DV-1006). A new antiulcer drug.Arch Toxicol. 1979 Sep;42(4):249-58. doi: 10.1007/BF00334838. Arch Toxicol. 1979. PMID: 391178